Sibelium T 5 mg


Tablet 60 tablets
scheduling status
S2
registration number
43/5.7.1/0451
What Sibelium T 5 mg is and what it is used for
Prophylaxis of classic (with aura) or common (without aura) migraine. Symptomatic treatment of vestibular vertigo (due to a diagnosed functional disorder of the vestibular system.
dosage
Migraine prophylaxis Starting dose: Two 5 mg tablets (10 mg) Sibelium at night for adult patients aged 18 to 64 years and 5 mg daily for elderly patients aged 65 years and older. If, during this treatment depressive, extrapyramidal or other unacceptable symptoms occur, administration should be discontinued. If, after 2 months of this initial treatment, no significant improvement is observed, the patient should be considered a non-responder and administration should be discontinued. Maintenance treatment: If a patient is responding satisfactorily and if a maintenance treatment is needed, the dose should be decreased to 5 days treatment at the same daily dose with two successive medicine free days every week. Even if the prophylactic maintenance treatment is successful and well tolerated, it should be interrupted after 6 months and it should be re-initiated only if the patient relapse. Vertigo The same daily dosages should be used as for migraine, but the starting treatment should not be given longer than needed for symptom control, which generally takes less than two months. After one month of treatment for chronic vertigo or after two months treatment for paroxysmal vertigo, no significant improvement is observed, the patient should be considered a non-responder and administration should be discontinued. The dose will be as described below; Take the same number of tablets you are used to taking (1 or half a tablet) every day before going to bed for 5 days in a row; and do not take any tablets for 2 days in a row. Repeat this pattern (5 days with medicine followed by 2 days with no medicine) for the rest of the treatment.
how to take
Refer to dosage.
What Sibelium T 5 mg contains
Flunarizine.
other ingredients
Maize starch, hypromellose 2910, polysorbate 20, microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate.
Therapeutic classification
Antihistaminic, anti-emetics and antivertigo preparations - Antihistamines.
© 2026 SAHPRA. ALL RIGHTS RESERVED